| Literature DB >> 19455205 |
Evelina Daskalova1, Vesselin Baev, Ventsislav Rusinov, Ivan Minkov.
Abstract
Recent research data reveal complex, network-based interactions between mobile elements and regulatory systems of eukaryotic cells. In this article, we focus on regulatory interactions between Alu elements and micro RNAs (miRNAs). Our results show that the majority of the Alu sequences inserted in 3'UTRs of analyzed human genes carry strong potential target sites for at least 53 different miRNAs. Thus, 3'UTR-located Alu elements may play the role of mobile regulatory modules that supply binding sites for miRNA regulation. Their abundance and ability to distribute a set of certain miRNA target sites may have an important role in establishment, extension, network organization, and, as we suppose - in the regulation and environment-dependent activation/inactivation of some elements of the miRNA regulatory system, as well as for a larger scale RNA-based regulatory interactions. The Alu-miRNA connection may be crucial especially for the primate/human evolution.Entities:
Keywords: retroelements; Alu elements; eukaryotic regulatory networks; evolution; miRNAs
Year: 2007 PMID: 19455205 PMCID: PMC2674674
Source DB: PubMed Journal: Evol Bioinform Online ISSN: 1176-9343 Impact factor: 1.625
Figure 1Mobile elements (MEs) and their relation to cellular regulatory processes. The connection between ret-roelements and miRNAs is the objective of current study.
Figure 2Distribution of target sites on the 3′UTR of the protein chemokine ligand 5 (NM_002985). It carries 2 Alu insertions in direct orientation: AluYc1 and AluS that have occupied 53,5% f the 3′UTR length. All six probable target sites with proper structure (red lines) map in the two Alu inserts. All the rest are ‘cryptic target sites’ with sequence complementarity to relevant miRNAs but without proper structure (green lines).
Some of the most abundant Alu-related miRNA target sites.
| Target sites for: | Number of occurrences in 3′UTRs as a whole | Number of occurrences in Alu inserts | Alu orientation |
|---|---|---|---|
| hsa-mir-20b | 121 | 114 | d |
| hsa-mir-17–5p | 118 | 111 | d |
| hsa-mir-20a | 111 | 105 | d |
| hsa-mir-106a | 110 | 103 | d |
| hsa-mir-92 | 103 | 99 | c, rarely d |
| hsa-mir-93 | 107 | 99 | d |
| hsa-mir-367 | 101 | 98 | c, rarely d |
| hsa-mir-25 | 101 | 97 | c, rarely d |
| hsa-let-7b | 57 | 40 | c, rarely d |
| hsa-mir-484 | 34 | 30 | d |
| hsa-mir-453 | 37 | 30 | c |
| hsa-let-7i | 29 | 24 | c&d |
| hsa-mir-346 | 23 | 15 | d |
| hsa-let-7c | 27 | 12 | c&d |
| hsa-mir-106b | 9 | 8 | d |
| hsa-mir-422a | 12 | 8 | c&d |
| hsa-mir-520g | 9 | 7 | d |
| hsa-mir-452 | 12 | 7 | c |
| hsa-mir-455 | 9 | 7 | d |
| hsa-mir-372 | 8 | 7 | d |
| hsa-let-7e | 14 | 7 | c |
| hsa-mir-187 | 12 | 7 | c |
| hsa-mir-378 | 13 | 6 | d |
| hsa-mir-197 | 9 | 5 | d |
| hsa-mir-339 | 14 | 5 | c&d |
| hsa-let-7g | 7 | 5 | c |
* This column denotes the orientation of the Alu insert in which the target sites are localized: ‘d’ is for direct (sense) orientation, ‘c’ – for complementary (antisense) orientation of the Alu inserts.
Figure 3Structures of some miRNA/mRNA duplexes at target sites localized in Alu insertions. 3′ end of miRNA is shown at the top of the figures, 5′—at the bottom. miRNAs are colored in red, mRNA targets – in black. (a) – (e) – target sites in antisense Alu insertions. over page: (f) – (j) target sites in sense Alu insertions.
14 main groups of proteins, defined on the base of most often occurring GOA keywords among the set of analyzed genes. The ratios ‘target sites/protein’ are shaded in yellow for total 3′UTRs and in light green for Alu inserts only. The 3 highest scores are shown in bold.
| Keyword | No proteins | % of all proteins | Total content of miRNA target sites | Content of miRNA target sites in | ||||
|---|---|---|---|---|---|---|---|---|
| MiRNAs, number | target sites, number | target sites/protein | MiRNAs, number | target sites, number | target sites/protein | |||
| Metabolism | 41 | 17,23 | 90 | 326 | 7,95 | 24 | 198 | 4,83 |
| Signal transduction | 36 | 15,13 | 99 | 299 | 8,31 | 26 | 145 | 4,03 |
| Transport | 36 | 15,13 | 83 | 306 | 8,50 | 26 | 179 | 4,97 |
| Regulation of transcription | 31 | 13,03 | 98 | 298 | 29 | 158 | 5,10 | |
| Development | 25 | 10,50 | 93 | 243 | 15 | 110 | 4,40 | |
| Immune response | 23 | 9,66 | 68 | 183 | 7,96 | 18 | 106 | 4,61 |
| Receptor | 23 | 9,66 | 77 | 205 | 8,91 | 25 | 106 | 4,61 |
| Nervous system | 18 | 7,56 | 67 | 165 | 9,17 | 20 | 97 | 5,39 |
| Cell cycle | 16 | 6,72 | 56 | 147 | 25 | 93 | ||
| Protein modification | 15 | 6,30 | 59 | 121 | 8,07 | 20 | 67 | 4,47 |
| Structural component | 12 | 5,04 | 46 | 88 | 7,33 | 19 | 46 | 3,83 |
| Apoptosis | 11 | 4,62 | 53 | 100 | 9,09 | 15 | 53 | 4,82 |
| Cell adhesion | 11 | 4,62 | 42 | 90 | 8,18 | 20 | 64 | |
| Information processing | 8 | 3,36 | 28 | 63 | 7,88 | 14 | 46 | 5,75 |
| In all 238 proteins: | ||||||||